3-Apr-2019
Council of Canadians
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
4-Mar-2019
The Hindu Business Line
Farmer and CSOs stressing that India should not agree to obligations with respect to IP on seed and planting materials at the RCEP negotiations as it hurt the livelihood of poor farmers.
25-Feb-2019
Forum against FTAs
A mega free trade agreement, like RCEP that undermines farmers’ seed freedoms in a mega diverse country, with seed diversity and farmers’ knowledge is unacceptable, say over 50 groups and citizens
22-Jan-2019
Public Citizen
In a letter to Congress, the groups demand that the pact’s giveaways to Big Pharma that would keep medicines unaffordable be removed before the pact is sent to Congress.
14-Jan-2019
Chicago Tribune
NAFTA 2.0 would effectively tie the US Congress’ hands in the struggle against rising drug prices.
14-Dec-2018
The Federal Council, The Portal of the Swiss Government
Indonesia - EFTA trade deal will be signed, 98 per cent of Swiss exports to Indonesia will be exempt from customs duties over the coming years.
5-Dec-2018
Public Citizen
The Intellectual Property Chapter of the revised NAFTA, rebranded by the Trump Administration USMCA, includes provisions that threaten to undermine critical efforts towards affordable health care and medicine.